Tuaminoheptane

Template:Chembox Beilstein Template:Chembox ECNumber Template:Chembox E number Template:Chembox RTECS Template:Chembox UNNumber Template:Chembox Appearance Template:Chembox Density Template:Chembox BoilingPt Template:Chembox LogP Template:Chembox RefractIndex Template:Chembox GHSPictograms Template:Chembox GHSSignalWord Template:Chembox HPhrases Template:Chembox PPhrases Template:Chembox FlashPt Template:Chembox Lethal amounts (set)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tuaminoheptane (or tuamine) is a nasal decongestant drug which is a sympathomimetic stimulant and vasoconstrictor.^[2] However, it can cause skin irritation,^[3] which limits its usefulness as a nasal decongestant. Oral preparations were once available, but are no longer produced. Side effects associated with the use of tuaminoheptane can include shortness of breath, tachycardia and hypertension.

Tuaminoheptane is on the 2011 list of prohibited substances published by the World Anti-Doping Agency.

References

↑ “tuamine – Compound Summary”. USA: National Center for Biotechnology Information. 25 March 2005. Identification and Related Records. Retrieved 31 May 2012.
↑ Delicado, E. G.; Fideu, M. D.; Miras-Portugal, M. T.; Pourrias, B.; Aunis, D. (1990). “Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells”. Biochemical Pharmacology. 40 (4): 821–825. doi:10.1016/0006-2952(90)90322-C. PMID 2386550.
↑ Raoux, M.; Colomban, C.; Delmas, P.; Crest, M. (2007). “The amine-containing cutaneous irritant heptylamine inhibits the volume-regulated anion channel and mobilizes intracellular calcium in normal human epidermal keratinocytes”. Molecular Pharmacology. 71 (6): 1685–1694. doi:10.1124/mol.106.033324. PMID 17384225.

Template:Stimulants

[1] “tuamine – Compound Summary”. USA: National Center for Biotechnology Information. 25 March 2005. Identification and Related Records. Retrieved 31 May 2012.

[2] Delicado, E. G.; Fideu, M. D.; Miras-Portugal, M. T.; Pourrias, B.; Aunis, D. (1990). “Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells”. Biochemical Pharmacology. 40 (4): 821–825. doi:10.1016/0006-2952(90)90322-C. PMID 2386550.

[3] Raoux, M.; Colomban, C.; Delmas, P.; Crest, M. (2007). “The amine-containing cutaneous irritant heptylamine inhibits the volume-regulated anion channel and mobilizes intracellular calcium in normal human epidermal keratinocytes”. Molecular Pharmacology. 71 (6): 1685–1694. doi:10.1124/mol.106.033324. PMID 17384225.

[2]

[3]

Tuaminoheptane

Overview

See also

References